Company Dashboard
Get the latest news, press releases, earnings, outlook, ratings, and dividends for any company.
Mirum Pharmaceuticals, Inc. ( NASDAQ : MIRM )
| Pre-Market | Intra-Day | After-Hours |
|---|---|---|
|
—
|
79.96
(
+0.34
/
+0.43%
)
|
—
|
| — | 14-Oct 16:00 | 13-Oct 19:04 |
| Previous Close | 79.62 | 52-Week Low | 63.23 |
| Open | 78.64 | 52-Week High | 130.00 |
| Day Low | 78.32 | 50-Day Average | 94.28 |
| Day High | 81.86 | 200-Day Average | 98.50 |
| Volume | 907.98 K | Market Cap | 4.88 B |
MIRM Earnings Calendar
Earnings reports, estimates, results and year-over-year growth for MIRM.
Showing
1 –
5
of
5
earnings records
from
2025-08-06
to
2026-08-05
| Symbol | Date | Time | Period | Metric | Actual | Estimate | Prior Year | Surprise | Growth | News |
|---|---|---|---|---|---|---|---|---|---|---|
| MIRM | 2026-08-05 | AMC | Q2 2026 | EPS | $-0.80 | $-0.68 | $-0.12 | Miss (-17.65%) | Down (-566.67%) | View |
| REV | $176.24 M | $166.12 M | $127.79 M | Beat (+6.09%) | Up (+37.91%) | |||||
| MIRM | 2026-05-06 | AMC | Q1 2026 | EPS | $-0.50 | $-0.35 | $-0.30 | Miss (-42.86%) | Down (-66.67%) | View |
| REV | $159.88 M | $149.54 M | $111.60 M | Beat (+6.91%) | Up (+43.26%) | |||||
| MIRM | 2026-02-25 | AMC | Q4 2025 | EPS | $-0.12 | $0.04 | $-0.49 | Miss (-400.00%) | Up (+75.51%) | View |
| REV | $148.93 M | $141.81 M | $99.41 M | Beat (+5.02%) | Up (+49.81%) | |||||
| MIRM | 2025-11-04 | AMC | Q3 2025 | EPS | $0.05 | $-0.17 | $-0.30 | Beat (+129.41%) | Up (+116.67%) | View |
| REV | $133.01 M | $130.07 M | $90.38 M | Beat (+2.26%) | Up (+47.17%) | |||||
| MIRM | 2025-08-06 | AMC | Q2 2025 | EPS | $-0.12 | $-0.33 | $-0.52 | Beat (+63.64%) | Up (+76.92%) | View |
| REV | $127.79 M | $107.91 M | $77.88 M | Beat (+18.42%) | Up (+64.09%) |
Sign up to see MORE news
Create your FREE CatalystPICR account to access MORE news and additional data.
Sign Up Free